Healthcare Providers


Healthcare Providers Can Prevent TB

Testing and treating latent TB infection is a critical step to eliminating TB in the United States and protecting your community. As a trusted source of health information, it’s important to initiate a conversation about latent TB infection and TB disease with your patients at risk for TB.


Risk Factors for Latent TB Infection & Development of Active TB Disease

While TB is common throughout the world, individuals who were born in or frequently travel to Asia, Africa, or Latin America have a higher chance of being infected with TB. People with HIV infection or who are immunocompromised, and who have latent TB infection, are more likely to develop active TB disease than others. If your patients fall into one of these categories, consider testing them for TB.


Testing for Latent TB Infection

Testing for TB infection should be a routine and integral part of health care for patients with increased risk for TB. TB blood tests or Interferon Gamma Release Assays should be considered for patients who have been vaccinated for TB with the Bacille Calmette-Guérin, or BCG vaccine. CDC and the U.S. Preventive Services Task Force (USPSTF) recommend testing people that are at increased risk for TB infection.


Explain the Testing Process

Treating Latent TB Infection

More than 80% of U.S. TB cases are believed to be associated with longstanding untreated latent TB infection. Shorter rifamycin-based treatment regimens for latent TB infection make it easier than ever for healthcare providers to treat latent TB infection to prevent TB disease. Resources such as treatment information brochures, and medication trackers and symptom checklists can help your patients complete the full course of treatment.


Professional Resources and Tools

There are resources available to support you in coding and billing for latent infection TB testing and treatment.

Additional Resources